ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $113,848 | -3.0% | 22,907 | -3.6% | 0.05% | -1.9% |
Q1 2023 | $117,382 | +14.4% | 23,761 | +45.6% | 0.05% | +35.0% |
Q4 2022 | $102,616 | -16.6% | 16,314 | +42.3% | 0.04% | -42.9% |
Q3 2022 | $123,000 | -37.6% | 11,468 | -33.9% | 0.07% | -35.8% |
Q2 2022 | $197,000 | +18.7% | 17,352 | -5.3% | 0.11% | +122.4% |
Q1 2022 | $166,000 | -32.2% | 18,329 | +92.0% | 0.05% | -9.3% |
Q3 2021 | $245,000 | +14.5% | 9,546 | +57.3% | 0.05% | +28.6% |
Q1 2021 | $214,000 | – | 6,067 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $45,386,000 | 9.32% |
TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $472,400,000 | 5.23% |
Wildcat Capital Management, LLC | 1,515,524 | $38,252,000 | 4.81% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 900,143 | $22,720,000 | 3.28% |
Coastal Bridge Advisors, LLC | 385,824 | $9,738,000 | 1.93% |
Casdin Capital, LLC | 945,000 | $23,852,000 | 0.71% |
DSAM Partners (London) Ltd | 208,798 | $5,270,000 | 0.62% |
BAINCO INTERNATIONAL INVESTORS | 152,839 | $3,858,000 | 0.44% |
Pier Capital, LLC | 152,071 | $3,838,000 | 0.41% |
Woodline Partners LP | 567,539 | $14,325,000 | 0.38% |